- Home
- PLAB vs BBOT Comparison
PLAB vs BBOT Comparison
Compare PLAB & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLAB | BBOT |
|---|---|---|
| Founded | 1969 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 1987 | N/A |
Fundamental Metrics
Financial Performance| Metric | PLAB | BBOT |
|---|---|---|
| Price | $32.90 | $11.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $43.50 | $23.80 |
| AVG Volume (30 Days) | ★ 1.9M | 164.1K |
| Earning Date | 12-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.09 | N/A |
| EPS | ★ 2.28 | N/A |
| Revenue | ★ $849,294,000.00 | N/A |
| Revenue This Year | $4.63 | N/A |
| Revenue Next Year | $6.20 | N/A |
| P/E Ratio | $15.07 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.46 | $8.50 |
| 52 Week High | $39.80 | $14.87 |
Technical Indicators
Market Signals| Indicator | PLAB | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 64.51 | N/A |
| Support Level | $35.69 | N/A |
| Resistance Level | $39.80 | N/A |
| Average True Range (ATR) | 1.87 | 0.00 |
| MACD | 1.07 | 0.00 |
| Stochastic Oscillator | 61.09 | 0.00 |
Price Performance
Historical ComparisonAbout PLAB Photronics Inc.
Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz or glass plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue world-wide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.